Company planning a demerger to unlock shareholders value ,as it is the only pharma company with lowest PE which is 10 , though company enjoys good revenue Also keep an eye on 20 EMA Can be bought for short time period
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.